Corneal and External Disorders
An Introduction to Corneal Disorders
Advances in the treatment of corneal diseases have been made in recent years. The introduction of collagen cross-linking has offered new options to patients with keratoconus, and advances in corneal transplantation with DMEK and DSAEK techniques have also improved the safety and outcomes for these patients.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
As artificial intelligence (AI), data science, and real-world evidence become increasingly important across ophthalmology, their potential is expanding beyond image analysis alone. From identifying clinical phenotypes in heterogeneous conditions such as dry eye disease to supporting risk stratification, patient education, and more personalized follow-up care, these approaches may help clinicians interpret complex data and improve decision-making in everyday practice. We spoke with Dr Germán MejÃa-Salgado (Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia) about how AI and real-world clinical data are being explored in ophthalmology, where these tools could add the most value beyond diagnostic imaging, and what will be needed for AI to become genuinely useful for ophthalmologists and their patients.
The 40th World Ophthalmology Congress (WOC2026) will take place at the Prague Congress Centre, Czech Republic, from June 26–29, 2026, bringing together ophthalmologists and eye care professionals from across the world
Lacripep has received US Food and Drug Administration (FDA) orphan drug and fast track designations for neurotrophic keratitis (NK), as TearSolutions begins dosing patients in a phase II clinical trial of the investigational topical therapy.1
Corneal ectatic disorders, such as keratoconus, progressively weaken corneal integrity, leading to thinning, irregular astigmatism and visual deterioration.1 Typically progressive in nature, these ectasias result in increasingly thinner corneas, causing the cornea to protrude forward into a cone shape. This ...
The 3rd World Keratoconus Congress (WKC 2026), held in Florence, brought together leading corneal specialists from around the world to discuss the latest advances in keratoconus diagnosis, treatment and long-term management. Across three days of scientific exchange, several clear themes emerged: the growing role of earlier, more precise diagnosis, continued innovation in personalised treatment strategies, and an increasing focus on functional and patient-centred outcomes.
Join us to read the latest news and abstract highlights from ASCRS 2026 The American Society of Cataract and Refractive Surgery Annual Meeting returned to Washington, D.C. from April 10–13, bringing together cataract, refractive, cornea and anterior segment specialists from around ...
As we’ve come to expect, the ASCRS 2026 Annual Meeting delivered a strong mix of practical insights and emerging innovation across corneal and ocular surface disease. This year’s programme highlighted clear progress in regenerative therapies, improved recognition and management of ocular surface pain, and a rapidly evolving dry eye landscape driven by novel mechanisms and faster-acting treatments.
Cataract surgery following penetrating keratoplasty (PKP) presents a unique set of challenges, requiring a careful balance between preserving graft integrity and achieving meaningful visual improvement. In this expert pearl, Prof. Dr Suphi Taneri shares his practical approach to managing these complex cases, from preoperative assessment and biometry to surgical technique and postoperative care.
The first months of 2026 have already seen a number of interesting studies and reviews published across the ophthalmology literature, setting the stage for another year of progress in the field. Below, we highlight a selection of recent papers from major journals that we found particularly notable over the past few weeks.
A recent study in Cell Reports reports that myopia may be associated not only with sensory retinal deficits but also with abnormal visuomotor responses during accommodation.
As 2026 gets underway, January has delivered a busy start across regulation, clinical research and community awareness. Here are some of the top news and research stories from the month.
As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchOPHTHALMOLOGY. From thought-provoking expert interviews and peer-reviewed research, to dynamic conference coverage and an expanding portfolio of medical education, this year has been ...
In this Q&A, Dr Emilio Torres-Neto discusses ELZA-PACE—the second-generation customised cross-linking technique designed to concentrate treatment precisely where the cornea is weakest—alongside the latest insights from the sub400 protocol for ultra-thin corneas and the role of ECO-CAIRS within a staged, individualised rehabilitation pathway.
In this interview Dr Michalina Depczyńska examinines the role of repeated corneal cross-linking (Re-CXL) in eyes showing progressive ectasia after initial treatment failure.
Read our Q&A with Prof. Hafezi, as he discusses the clinical evidence behind high-fluence CXL, the latest insights into ELZA-sub400 for ultra-thin corneas, and what these developments mean for the future of personalized CXL care.
The US FDA has approved a new topical therapy for keratoconus, marking the first corneal cross-linking treatment that does not require surgical removal of the corneal epithelium. The approval, announced by Glaukos Corporation, addresses a significant gap in treatment options for this progressive and often underdiagnosed rare disease.
With the second half of 2025 underway, we asked our  touchOPHTHALMOLOGY Future Leaders 2025 to share the developments they believe will shape the future of the field. Here, they highlight four exciting areas that look set to change practice - not only as the year draws to a close, but well into the future.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
